Laiyemo Adeyinka O, Jack Momodu, Dawkins Fitzroy W, Smoot Duane T
Cancer Prevention Fellowship Program, Office of Preventive Oncology, Biometry Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, 6130 Executive Blvd, Rm 3121, Bethesda, MD 20892-7354, USA.
J Natl Med Assoc. 2009 Aug;101(8):808-9. doi: 10.1016/s0027-9684(15)31011-7.
We report a 22-year-old man who presented with a 2-week history of intermittent melena and worsening scrotal and leg swelling. His medical history was significant for testicular cancer for which he had undergone orchiectomy, lymphadenectomy, and platinum-based chemotherapy. Esophagogastroduodenoscopy (EGD) performed revealed polypoid mass lesions in the second and third portions of the duodenum. Biopsy revealed mixed germ cell tumor with immature teratoma, the same histology as his testicular cancer. His chemotherapy was changed to an ifosphamide-based regimen and a repeat upper endoscopic examination 5 months later revealed complete resolution of previously noted polypoid duodenal mass lesions. This also demonstrates the effectiveness of ifosphamide as second-line therapy in the setting of resistance to platinum-based therapy.
我们报告一名22岁男性,有2周间歇性黑便病史,阴囊及腿部肿胀加重。他有睾丸癌病史,曾接受睾丸切除术、淋巴结清扫术及铂类化疗。食管胃十二指肠镜检查(EGD)显示十二指肠第二和第三部分有息肉样肿块病变。活检显示为混合性生殖细胞肿瘤伴未成熟畸胎瘤,组织学与他的睾丸癌相同。他的化疗方案改为以异环磷酰胺为基础的方案,5个月后再次进行上消化道内镜检查显示先前发现的十二指肠息肉样肿块病变完全消退。这也证明了异环磷酰胺作为铂类治疗耐药情况下二线治疗的有效性。